Education

BA, 1988, Stanford University, Economics
BS, 1988, Stanford University, Biology
MD, 1992, Duke University, Durham, NC
Residency, 1992-1994, General Surgery, Stanford University, Stanford, CA
Residency, 1994-1998, Urologic Surgery, Stanford University, Stanford, CA
Masters of Health Administration, 2017, University of North Carolina at Chapel Hill

Honors & Awards

  • 2018, 2016, 2015
    UNC Health Care and Faculty Physicians Award for Carolina Care Excellence
  • 2018, 2017, 2016, 2015, 2014, 2013, 2011-2012, 2007-2008, 2006-2007, 2005-2006, 2004-2005, 2003-04
    "Best Doctors in America"
  • 2012, 2010-2011
    Castle and Connolly's "America's Top Doctors"
  • 2011-2012
    Faculty Teaching Award ("Attending of the Year"), Division of Urologic Surgery
  • 2010-2011
    America's Top Doctors for Cancer
  • 2010
    "Best Doctors in North Carolina"

Selected Publications

  1. Warren CJ, Reitblat CR, Ferreri CA, Eyrich NW, Daignault-Newton S, Andino JJ, Sadeghi-Nejad H, Pruthi RS, Kraft KH. Virtual "Matchmaking": Stakeholder Perspectives on the Future of the Urology Residency Match. Urology. 2022 Mar 06.  View on PubMed
  2. Chou J, Trepka K, Sjöström M, Egusa EA, Chu CE, Zhu J, Chan E, Gibb EA, Badura ML, Contreras-Sanz A, Stohr BA, Meng MV, Pruthi RS, Lotan Y, Black PC, Porten SP, Koshkin VS, Friedlander TW, Feng FY. TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells. Eur Urol Oncol. 2022 Feb 22.  View on PubMed
  3. Chu CE, Sjöström M, Egusa EA, Gibb EA, Badura ML, Zhu J, Koshkin VS, Stohr BA, Meng MV, Pruthi RS, Friedlander TW, Lotan Y, Black PC, Porten SP, Feng FY, Chou J. Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin. Clin Cancer Res. 2021 09 15; 27(18):5123-5130.  View on PubMed
  4. Chaudhary R, Padrnos L, Wysokinska E, Pruthi R, Misra S, Sridharan M, Wysokinski W, McBane RD, Houghton DE. Macrovascular Thrombotic Events in a Mayo Clinic Enterprise-Wide Sample of Hospitalized COVID-19-Positive Compared With COVID-19-Negative Patients. Mayo Clin Proc. 2021 07; 96(7):1718-1726.  View on PubMed
  5. de Kouchkovsky I, Zhang L, Philip EJ, Wright F, Kim DM, Natesan D, Kwon D, Ho H, Ho S, Chan E, Porten SP, Wong AC, Desai A, Huang FW, Chou J, Oh DY, Pruthi RS, Fong L, Small EJ, Friedlander TW, Koshkin VS. TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor. J Immunother Cancer. 2021 05; 9(5).  View on PubMed
  6. McMahon S, Basak R, Zhou X, Smith AB, Song L, Pruthi RS, Wallen EM, Nielsen ME, Tan HJ. Patient-reported Health Status, Comorbidity Burden, and Prostate Cancer Treatment. Urology. 2021 03; 149:103-109.  View on PubMed
  7. Chu CE, Law L, Zuniga K, Lin TK, Tsourounis C, Rodriguez-Monguio R, Lazar A, Washington SL, Cooperberg MR, Greene KL, Carroll PR, Pruthi RS, Meng MV, Chen LL, Porten SP. Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy. Urology. 2021 Mar; 149:168-173.  View on PubMed
  8. Lee A, Namiri N, Rios N, Enriquez A, Hampson LA, Pruthi RS, Breyer BN. Dedicated Residency Research Time and Its Relationship to Urologic Career Academic Success. Urology. 2021 02; 148:64-69.  View on PubMed
  9. Lonergan PE, Washington Iii SL, Branagan L, Gleason N, Pruthi RS, Carroll PR, Odisho AY. Rapid Utilization of Telehealth in a Comprehensive Cancer Center as a Response to COVID-19: Cross-Sectional Analysis. J Med Internet Res. 2020 07 06; 22(7):e19322.  View on PubMed
  10. Rosen GH, Murray KS, Greene KL, Pruthi RS, Richstone L, Mirza M. Effect of COVID-19 on Urology Residency Training: A Nationwide Survey of Program Directors by the Society of Academic Urologists. J Urol. 2020 11; 204(5):1039-1045.  View on PubMed
  11. Gan ZS, Wood CM, Pruthi RS. AUTHOR REPLY. Urology. 2020 05; 139:77.  View on PubMed
  12. Gan ZS, Wood CM, Hayon S, Deal A, Smith AB, Tan HJ, Pruthi RS. Correlation of Relative Value Units With Surgical Complexity and Physician Workload in Urology. Urology. 2020 05; 139:71-77.  View on PubMed
  13. Venkatramani V, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS, Weizer AZ, Konety BR, Tollefson M, Krupski TL, Smith ND, Shabsigh A, Barocas DA, Quek ML, Dash A, Kibel AS, Pruthi RS, Montgomery JS, Weight CJ, Sharp DS, Chang SS, Cookson MS, Gupta GN, Gorbonos A, Uchio EM, Skinner E, Soodana-Prakash N, Becerra MF, Swain S, Kendrick K, Smith JA, Thompson IM, Parekh DJ. Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup. J Urol. 2020 03; 203(3):522-529.  View on PubMed
  14. Filippou P, Mahajan S, Deal A, Wallen EM, Tan HJ, Pruthi RS, Smith AB. The Presence of Gender Bias in Letters of Recommendations Written for Urology Residency Applicants. Urology. 2019 12; 134:56-61.  View on PubMed
  15. Parekh DJ, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS, Weizer AZ, Konety BR, Tollefson M, Krupski TL, Smith ND, Shabsigh A, Barocas DA, Quek ML, Dash A, Kibel AS, Shemanski L, Pruthi RS, Montgomery JS, Weight CJ, Sharp DS, Chang SS, Cookson MS, Gupta GN, Gorbonos A, Uchio EM, Skinner E, Venkatramani V, Soodana-Prakash N, Kendrick K, Smith JA, Thompson IM. Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet. 2018 06 23; 391(10139):2525-2536.  View on PubMed
  16. Lotan Y, Black PC, Caba L, Chang SS, Cookson MS, Daneshmand S, Kamat AM, McKiernan JM, Pruthi RS, Ritch CR, Steinberg GD, Svatek RS, Zwarthoff EC. Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review. Eur Urol Oncol. 2018 08; 1(3):223-230.  View on PubMed
  17. Kardos J, Wobker SE, Woods ME, Nielsen ME, Smith AB, Wallen EM, Pruthi RS, Hayward MC, McGinty KA, Grilley-Olson JE, Patel NM, Weck KE, Black P, Parker JS, Milowsky MI, Hayes DN, Kim WY. Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable Phenotype. JCO Precis Oncol. 2017; 1.  View on PubMed
  18. Langston JP, Duszak R, Orcutt VL, Schultz H, Hornberger B, Jenkins LC, Hemingway J, Hughes DR, Pruthi RS, Nielsen ME. The Expanding Role of Advanced Practice Providers in Urologic Procedural Care. Urology. 2017 08; 106:70-75.  View on PubMed
  19. Pruthi RS, Filippou P. Editorial Comment. Urology. 2017 06; 104:83.  View on PubMed
  20. McCormick BJ, Pruthi RS. The Present and Future Challenges Facing Urology Departments at Academic Health Centers. Urology. 2017 Jun; 104:25-30.  View on PubMed

Go to UCSF Profiles, powered by CTSI